Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | viral clearance | |||
Anhui Zhifei Longcom | 0 | - | - | - | - | |
CoVax-19 SpikoGen | 0 | - | - | - | - | |
Nuvaxovid (NVX-CoV2373) Novavax | 0 | - | - | - | - | |
Sanofi/GSK recombinant protein vaccine | 0 | - | - | - | - | |
SCB-2019 | 0 | - | - | - | - |